Stay updated on LN-144 in Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the LN-144 in Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the LN-144 in Metastatic Uveal Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe page now displays the study record for a trial of lifileucel in people with advanced uveal melanoma and sarcomas, including participation details, contacts, and study measures, instead of a 403 error.SummaryDifference59%

- Check16 days agoChange DetectedA notice announces NIH website updates and says the term “Super Intelligence” is being used in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check22 days agoChange DetectedThe footer’s site revision identifier updates from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check29 days agoChange DetectedThe site revision displayed in the footer changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now shows a 403 Forbidden error with a Home link, replacing the usual study record content. This reflects a site access issue that prevents viewing the study details.SummaryDifference0.5%

- Check50 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study record content and navigation. This indicates that access to the study details is blocked and only the error information is visible.SummaryDifference20%

Stay in the know with updates to LN-144 in Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-144 in Metastatic Uveal Melanoma Clinical Trial page.